zPREDICTA to join forces with Science Exchange
The partnership will offer unique patient-derived 3D cell culture services to drug development researchers
The partnership will offer unique patient-derived 3D cell culture services to drug development researchers
Instrument is designed to reduce the number of parts requiring disinfection after use
Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago
Paragon Genomics announced the two products at the 2019 Association for Molecular Pathology (AMP)
Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment
Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®
Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies
Next-generation sequencing discovery pools enable larger custom panels and low sample numbers to speed up discovery
Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization
The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer
New collaboration to focus on developing potent Affimer-drug conjugates
Combining urine strip reading and digital microscopy, the LAURA XL delivers fully automated processing of urine samples
Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.
Corning Elplasia plates and Matrigel matrix for organoid culture are designed to help develop more predictive models for cancer and other critical diseases
Automated system designed to increase efficiency in cell therapy research
SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field
Discover how one lab is using patient-derived pancreatic organoids to deliver personalized treatments
Join this expert webinar to find out all you need to know about an innovative new method for tackling the first step of mAb purification
Roche's assay to be used to find patients eligible for treatment with Tecentriq in combination with Abraxane